• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

北美风湿病研究人员联盟(CORRONA)登记处中影响类风湿性关节炎患者骨折风险、T值及骨质疏松管理的因素。

Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry.

作者信息

Coulson Kathryn A, Reed George, Gilliam Brooke E, Kremer Joel M, Pepmueller Peri H

机构信息

Division of Rheumatology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.

出版信息

J Clin Rheumatol. 2009 Jun;15(4):155-60. doi: 10.1097/RHU.0b013e3181a5679d.

DOI:10.1097/RHU.0b013e3181a5679d
PMID:19363452
Abstract

OBJECTIVES

This study examined a wide array of clinical factors to evaluate their influence on fracture risk and T scores in women with rheumatoid arthritis (RA) and determine if women with RA who are at risk for osteoporosis (OP) are adequately treated with OP medications.

METHODS

Data from 8419 female RA patients participating in the Consortium of Rheumatology Researchers of North America registry from March 02, 2006 to August 15, 2006 was evaluated. Covariates included medication subgroups, demographic, and clinical parameters. Lumbar spine and hip T scores and fracture rates were studied in relation to the variables. Use of OP medications in patients with OP risk factors was also evaluated.

RESULTS

Postmenopausal status and higher modified health assessment questionnaire score (mHAQ) had a negative effect on lumbar spine score,while marriage, education, and body mass index had a positive effect. A similar trend was found with hip T scores. Increase in overall fracture risk correlated with postmenopausal status, mHAQ, and prednisone use, while tumor necrosis factor monotherapy was associated with decreased overall fracture risk. mHAQ was also associated with nonhip/nonspine fractures. Eighty percent of patients had at least 1 risk factor for OP, but only 32% were on OP medications. Only 54% of patients with 3 risk factors were on OP medication.

CONCLUSIONS

In RA, postmenopausal status, mHAQ, and prednisone use were associated with a higher overall fracture risk. Women with RA who were at risk for OP may have been inadequately treated with OP medications.

摘要

目的

本研究考察了一系列临床因素,以评估它们对类风湿关节炎(RA)女性骨折风险和T值的影响,并确定有骨质疏松症(OP)风险的RA女性是否得到了OP药物的充分治疗。

方法

对2006年3月2日至2006年8月15日参与北美风湿病研究人员联盟注册研究的8419名女性RA患者的数据进行了评估。协变量包括药物亚组、人口统计学和临床参数。研究了腰椎和髋部T值及骨折率与这些变量的关系。还评估了有OP风险因素的患者使用OP药物的情况。

结果

绝经后状态和较高的改良健康评估问卷评分(mHAQ)对腰椎评分有负面影响,而婚姻、教育程度和体重指数则有正面影响。髋部T值也发现了类似趋势。总体骨折风险的增加与绝经后状态、mHAQ和泼尼松的使用相关,而肿瘤坏死因子单药治疗与总体骨折风险降低相关。mHAQ也与非髋部/非脊柱骨折相关。80%的患者至少有1个OP风险因素,但只有32%的患者使用OP药物。有3个风险因素的患者中只有54%使用OP药物。

结论

在RA中,绝经后状态、mHAQ和泼尼松的使用与较高的总体骨折风险相关。有OP风险的RA女性可能未得到OP药物的充分治疗。

相似文献

1
Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry.北美风湿病研究人员联盟(CORRONA)登记处中影响类风湿性关节炎患者骨折风险、T值及骨质疏松管理的因素。
J Clin Rheumatol. 2009 Jun;15(4):155-60. doi: 10.1097/RHU.0b013e3181a5679d.
2
Fall-related risk factors and osteoporosis in women with rheumatoid arthritis.类风湿关节炎女性的跌倒相关危险因素与骨质疏松症
Rheumatology (Oxford). 2004 Oct;43(10):1267-71. doi: 10.1093/rheumatology/keh304. Epub 2004 Jul 13.
3
Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.活动性类风湿关节炎患者在抗TNF-α治疗期间的骨代谢变化。
Ann N Y Acad Sci. 2006 Jun;1069:420-7. doi: 10.1196/annals.1351.040.
4
Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.硬皮病患者可能有更高的骨质疏松风险。与类风湿关节炎和非炎性肌肉骨骼疾病的比较。
J Rheumatol. 2008 Jun;35(6):1073-8. Epub 2008 Apr 15.
5
Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.类风湿关节炎患者糖皮质激素诱导性骨质疏松的管理:学术性风湿病诊疗实践中的治疗率及预测因素
Arthritis Rheum. 2002 Dec;46(12):3136-42. doi: 10.1002/art.10613.
6
Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.基于人群的骨特异性药物降低骨质疏松性骨折风险有效性研究。
Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):248-59. doi: 10.1002/pds.1551.
7
Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis.系统性硬化症女性骨质疏松症和骨折风险增加:与类风湿关节炎的对比研究。
Arthritis Care Res (Hoboken). 2012 Dec;64(12):1871-8. doi: 10.1002/acr.21761.
8
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis.近期发病的类风湿关节炎患者手部及全身骨密度的变化
Ann Rheum Dis. 2009 Mar;68(3):330-6. doi: 10.1136/ard.2007.086348. Epub 2008 Mar 28.
9
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.近期发病的活动性类风湿关节炎患者的骨密度变化
Ann Rheum Dis. 2008 Jun;67(6):823-8. doi: 10.1136/ard.2007.073817. Epub 2007 Jul 20.
10
The osteoporosis needs of patients with wrist fracture.腕部骨折患者对骨质疏松症的需求。
J Orthop Trauma. 2008 Sep;22(8 Suppl):S73-8. doi: 10.1097/BOT.0b013e31815e9ff7.

引用本文的文献

1
Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.类风湿关节炎与后续骨折风险:一项个体水平的荟萃分析以更新FRAX工具
Osteoporos Int. 2025 Apr;36(4):653-671. doi: 10.1007/s00198-025-07397-1. Epub 2025 Feb 16.
2
Significant decrease of osteoporosis and osteoporotic fractures in rheumatoid arthritis within a period of 24 years: experiences of a single centre.24 年内类风湿关节炎患者骨质疏松症和骨质疏松性骨折的显著减少:单中心经验。
RMD Open. 2024 Aug 20;10(3):e004564. doi: 10.1136/rmdopen-2024-004564.
3
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.
类风湿关节炎与骨质疏松症的相互作用:探索发病机制及药理学方法。
Clin Rheumatol. 2024 May;43(5):1421-1433. doi: 10.1007/s10067-024-06932-5. Epub 2024 Mar 18.
4
Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years.类风湿关节炎的长期骨折风险:早期持续达到疾病活动度评分28(DAS28)缓解及功能恢复、进行性侵蚀性疾病、体重指数、自身抗体阳性和糖皮质激素的影响。一项为期10年的队列研究。
BMC Rheumatol. 2023 Aug 7;7(1):23. doi: 10.1186/s41927-023-00347-6.
5
Protocol for the pilot randomized trial of the CArdiovascular Risk assEssment for Rheumatoid Arthritis (CARE RA) intervention: a peer coach behavioral intervention.类风湿关节炎心血管风险评估(CARE RA)干预的试点随机试验方案:同伴指导行为干预
Pilot Feasibility Stud. 2022 Apr 15;8(1):84. doi: 10.1186/s40814-022-01041-z.
6
Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.类风湿关节炎相关心血管疾病、骨质疏松和间质性肺病等合并症管理的共识建议。
Medicine (Baltimore). 2022 Jan 7;101(1):e28501. doi: 10.1097/MD.0000000000028501.
7
Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis.类风湿关节炎患者椎体骨折的发病率及危险因素:一项更新的荟萃分析
Clin Rheumatol. 2022 May;41(5):1313-1322. doi: 10.1007/s10067-021-06046-2. Epub 2022 Jan 10.
8
Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients.巴多昔芬预防类风湿关节炎患者糖皮质激素性骨丢失的疗效。
Arthritis Res Ther. 2021 Jul 2;23(1):176. doi: 10.1186/s13075-021-02564-1.
9
Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs.接受生物制剂或靶向合成改善病情抗风湿药物治疗的类风湿关节炎患者非椎体骨折的比较风险
ACR Open Rheumatol. 2021 Aug;3(8):531-539. doi: 10.1002/acr2.11292. Epub 2021 Jul 1.
10
Update on Glucocorticoid Induced Osteoporosis.糖皮质激素性骨质疏松症的最新进展。
Endocrinol Metab (Seoul). 2021 Jun;36(3):536-543. doi: 10.3803/EnM.2021.1021. Epub 2021 Jun 1.